Alfavision Overseas (India) Limited (BOM:531156)
14.99
+0.29 (1.97%)
At close: Apr 10, 2026
BOM:531156 Market Cap
BOM:531156 has a market cap or net worth of 472.57 million as of April 10, 2026. Its market cap has increased by 12.28% in one year.
Market Cap
472.57M
Enterprise Value
1.83B
Revenue
13.30M
Ranking
n/a
PE Ratio
n/a
Stock Price
14.99
Market Cap Chart
Since October 21, 2004, BOM:531156's market cap has increased from 14.19M to 472.57M, an increase of 3,231.11%. That is a compound annual growth rate of 17.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 472.57M | 151.93% |
| Dec 31, 2025 | 187.58M | -57.19% |
| Dec 31, 2024 | 438.21M | -22.95% |
| Dec 29, 2023 | 568.73M | 43.63% |
| Dec 30, 2022 | 395.97M | 1.01% |
| Dec 31, 2021 | 392.03M | 328.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kimia Biosciences | 1.43B |
| Panchsheel Organics | 1.43B |
| Krebs Biochemicals & Industries | 1.25B |
| Smruthi Organics | 1.23B |
| Tyche Industries | 1.22B |
| Resonance Specialties | 1.02B |
| Bacil Pharma | 852.14M |
| Vasundhara Rasayans | 421.75M |